Changes in macular function after Ozurdex for retinal vein occlusion

Optometry and Vision Science

Volumn 91, Issue 7, 2014, Pages 760-768

  Querques, Giuseppe ^a,b,c   Cascavilla, Maria Lucia ^a   Cavallero, Edoardo ^a   Triolo, Giacinto ^a   Querques, Lea ^a   Lattanzio, Rosangela ^a   Cicinelli, Maria Vittoria ^a   Preziosa, Chiara ^a   Borrelli, Enrico ^a   Bandello, Francesco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

dexamethasone implant; microperimetry; multifocal electroretinography; optical coherence tomography; Ozurdex; retinal vein occlusion

Indexed keywords

OPTICAL TOMOGRAPHY; PATIENT TREATMENT; VISION;

DEXAMETHASONES; ELECTRORETINOGRAPHY; MICROPERIMETRY; OZURDEX; RETINAL VEIN OCCLUSION;

OPHTHALMOLOGY;

DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; DRUG IMPLANT; ELECTRORETINOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; PROSPECTIVE STUDY; RETINA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETREATMENT; VISUAL ACUITY; VISUAL FIELD; VITREOUS BODY;

DEXAMETHASONE; DRUG IMPLANTS; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; RETINAL VEIN OCCLUSION; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS; VITREOUS BODY;

EID: 84903786809     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000308     Document Type: Article

References (26)

1. Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event. Surv Ophthalmol 2011;56:281-99.
2. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-82.
3. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-33.
4. Bressler NM, Schachat AP. Management of macular edema from retinal vein occlusions: you can never have too many choices. Ophthalmology 2010;117:1061-3.
5. Goldfien A. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung BG, ed. Basic and Clinical Pharmacology, 6th ed. London, UK: Prentice Hall International; 1995:592-607.
6. Ozurdex® [Package insert]. Irvine, CA: Allergan Inc.; 2009.
7. Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, Whitcup SM. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 2007; 125:309-17. (Pubitemid 46425557)
8. Haller JA, Bandello F, Belfort R, Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-46.
9. Haller JA, Bandello F, Belfort R, Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM, Li J. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011;118:2453-60.
10. Querques L, Querques G, Lattanzio R, Gigante SR, Del Turco C, Corradetti G, Cascavilla ML, Bandello F. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Ophthalmologica 2013;229:21-5.
11. Parodi MB, Iacono P, De Benedetto U, Cascavilla M, Bandello F. Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion. J Ocul Pharmacol Ther 2012;28:566-8.
12. Parodi MB, Iacono P, Cascavilla M, Zucchiatti I, Bandello F. Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting. Acta Ophthalmol 2012;90:e322-3.
13. Rishi P, Rishi E, Kuniyal L, Mathur G. Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: a case series. Oman J Ophthalmol 2012;5:79-82.
14. Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, Welty D. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci 2011;52:80-6.
15. Kiss CG, Barisani-Asenbauer T, Simader C, Maca S, Schmidt-Erfurth U. Central visual field impairment during and following cystoid macular oedema. Br J Ophthalmol 2008;92:84-8.
16. Senturk F, Ozdemir H, Karacorlu M, Karacorlu SA, Uysal O. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion. Retina 2010;30:1254-61.
17. Moschos MM, Brouzas D, Loukianou E, Apostolopoulos M, Moschos M. Intraocular triamcinolone acetonide for macular edema due to CRVO. A multifocal-ERG and OCT study. Doc Ophthalmol 2007;114:1-7. (Pubitemid 46206510)
18. Rohrschneider K, Bultmann S, Springer C. Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog Retin Eye Res 2008;27:536-48.
19. Sutter EE, Tran D. The field topography of ERG components in man-I. The photopic luminance response. Vision Res 1992;32:433-46.
20. Chen TC, Cense B, Pierce MC, Nassif N, Park BH, Yun SH, White BR, Bouma BE, Tearney GJ, de Boer JF. Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 2005;123:1715-20. (Pubitemid 41785106)
21. Nassif N, Cense B, Park BH, Yun SH, Chen TC, Bouma BE, Tearney GJ, de Boer JF. In vivo human retinal imaging by ultrahighspeed spectral domain optical coherence tomography. Opt Lett 2004; 29:480-2.
22. Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y, International Society for Clinical Electrophysiology of Vision. Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 2003;106:105-15. (Pubitemid 36355951)
23. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009;147:644-52.
24. Parravano M, Oddone F, Boccassini B, Giorno P, Chiaravalloti A, Tedeschi M, Scarinci F, Varano M. Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in macular edema due to retinal vein occlusion. Ophthalmic Res 2014;51:153-60.
25. Karacorlu M, Ozdemir H, Senturk F, Arf Karacorlu S, Uysal O. Macular function by multifocal electroretinogram in diabetic macular edema after intravitreal triamcinolone acetonide injection. Eur J Ophthalmol 2008;18:601-8.
26. Mathew R, Pearce E, Muniraju R, Abdul-Hey A, Sivaprasad S. Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1). Eye (Lond) 2014;28:318-26.